Bio Farma Prepares 18 Million Covid-19 Vaccine Doses for May
Translator
Ricky Mohammad Nugraha
Jumat, 30 April 2021 13:09 WIB
TEMPO.CO Jakarta State-pharmaceutical firm Bio Farma announced on Thursday that it has prepared up to 18 million doses of Covid-19 vaccine for May 2021, from the 59.5 million Sinovac bulk doses the government imported from China.
The government’s spokesperson for the Bio Farma vaccination, Bambang Heriyanto, said the 16-18 million doses came from production in April this year.
“We surely hope it passes inspection and obtains the lot release from the Food and Drug Monitoring Agency (BPOM) in May,” Bambang wrote in a written statement on April 29.
From the initial goal of producing 47 million doses, Bio Farma has already produced 41 million of them with 25 million doses obtaining approval from the BPOM. It has distributed 22.5 million doses through the Health Ministry to Indonesian provinces.
The vaccines that were distributed include 3 million CoronaVac shots and 1.1 million doses of AstraZeneca vaccines.
Read: Health Minister: Covid-19 Vaccine Supply from China Runs Smoothly
MUHAMMAD HENDARTYO
Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste
2 Januari 2024
Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste
Here is the list of the top 3 news on Tempo English today.
Read More
Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups
2 Januari 2024
Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups
Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.
Read More
Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia
2 Agustus 2023
Bio Farma, MSD to Launch NusaGard Cervix Cancer Vaccines in Indonesia
Bio Farma collaborates with MSD to launch NusaGard vaccines, the domestically produced human papillomavirus (HPV) vaccine.
Read More
Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022
21 Juni 2023
Bio Farma 'Post-Covid' Earnings Slump 50 Percent in 2022
The consolidated earnings logged by Bio Farma nosedived to Rp21.54 trillion in 2022, which is a 50.4 percent drop.
Read More
Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free
12 Juni 2023
Indonesian Health Ministry Provides 4 Million COVID-19 Vaccine Doses for Free
The Health Ministry distributing COVID-19 vaccine doses free of charge to the public.
Read More
Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria
30 Mei 2023
Indonesia's Bio Farma Sends 1.5 Million Pentavalent Vaccines to Nigeria
Bio Farma on Tuesday sent 1.5 million pentavalent vaccine doses under the Pentabio trade brand to Nigeria.
Read More
Indonesia's Bio Farma Opens Vaccine Technology Transfer with Ghana
21 Mei 2023
Indonesia's Bio Farma Opens Vaccine Technology Transfer with Ghana
Indonesia's pharmaceutical company PT Bio Farma has opened the opportunity for vaccine technology transfer with the Republic of Ghana, West Africa
Read More
Bio Farma and MSD Partner Up in Local HPV Vaccine Production
15 Mei 2023
Bio Farma and MSD Partner Up in Local HPV Vaccine Production
Bio Farma received the technical vision from Merck Sharp Dohme (MSD) in the development of locally-produced Human Papillomavirus (HPV) vaccine.
Read More
Jokowi Recalls Decision against Lockdown in Early Pandemic: 'I Meditate for 3 Days'
26 Januari 2023
Jokowi Recalls Decision against Lockdown in Early Pandemic: 'I Meditate for 3 Days'
President Joko "Jokowi" Widodo has again talked about his decision not to impose a lockdown at the beginning of the COVID-19 pandemic.
Read More
Indonesia Starts Offering Second COVID-19 Vaccine Booster for Public Starting Jan. 24
23 Januari 2023
Indonesia Starts Offering Second COVID-19 Vaccine Booster for Public Starting Jan. 24
Indonesian Ministry of Health is set to start administering a second COVID-19 vaccine booster for the public on Tuesday, January 24, 2023.
Read More
Recomended
17 Juni 2022
17 Juni 2022
17 Juni 2022
17 Juni 2022
17 Juni 2022
16 Juni 2022
16 Juni 2022
16 Juni 2022
16 Juni 2022
16 Juni 2022
